Projecting the impact of delayed access to elexacaf tor/tezacaf tor/ivacaf tor for people with Cystic Fibrosis *

Stanojevic, S; Vukovojac, K; Sykes, J; Ratjen, F; Tullis, E; Stephenson, AL

Stanojevic, S (corresponding author), Hosp Sick Children, Translat Med, Toronto, ON, Canada.; Stanojevic, S (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Stanojevic, S (corresponding author), Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada.

JOURNAL OF CYSTIC FIBROSIS, 2021; 20 (2): 243

Abstract

Background: Therapies that target the underlying defect in Cystic Fibrosis (CF) will likely impact the future characteristics of the CF population and......

Full Text Link